Advent Venture Partners
Advent Venture Partners is a growth and venture capital investors in market-leading tech and life sciences businesses.
Business Model: B2B
Revenue: $15M
Employees: 11-50
Rankings
Detailed Advent Venture Partners Information
Geographic Data
Address: 27 Beak Street
City: London
State: england
Zip: W1F 9RU
Country: GB
Financial Info
Stage:
Raised Last:
$0
Raised Total:$234M
Social
Twitter
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Advent Venture Partners is one of Europe&s;s most successful growth and venture capital investors in market-leading tech and life sciences businesses. They have designed their strategy, teams and funds so they can focus on backing a select few companies. They pride their selves on establishing true partnerships with entrepreneurs in order to build valuable businesses together.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 12/2004 | Rhytec | Venture Round | 15.4M |
| 7/2003 | Southampton Photonics | Series B | - |
| 9/2007 | Audium Semiconductor | Series A | 8.5M |
| 1/2007 | Celoxica | Venture Round | 0 |
| 9/2004 | Citel Technologies | Venture Round | 0 |
| 6/2006 | BridgeCo | Series D | 23M |
| 5/2011 | Prexa | Series B | 7M |
| 12/2012 | Avidex | Venture Round | 16.2M |
| 3/2007 | The Fizzback Group | Series A | 5M |
| 8/2007 | BridgeCo | Venture Round | 17M |
| 9/2010 | AmberFin | Venture Round | - |
| 6/2019 | Acutus Medical | Series D | 0 |
| 1/2007 | 4-Antibody AG | Series A | 18.4M |
| 5/2003 | Santarus | Series D | 51.4M |
| 11/2004 | K2 Optronics | Series C | 6.4M |
| 2/2011 | Conatus Pharmaceuticals | Series B | 0 |
| 10/1999 | Devgen | Series B | 24.7M |
| 11/2003 | NeoGuide Systems | Series B | 0 |
| 5/2011 | Ampla Pharmaceuticals | Venture Round | 1.5M |
| 5/2014 | Farfetch | Series D | 66M |
| 1/2012 | Farfetch | Series B | 0 |
| 10/2009 | Dailymotion | Series C | 0 |
| 2/2002 | Microscience | Series C | 36.4M |
| 2/2008 | Wisair | Series D | 0 |
| 3/2001 | Santarus | Series C | 33.2M |
| 5/2005 | Riskclick | Series C | 0 |
| 3/2021 | Wiz | Series B | 130M |
| 8/2006 | Thiakis | Series A | 19M |
| 2/2011 | CellNovo | Series B | 48.3M |
| 1/2008 | CellNovo | Series A | - |
| 3/2008 | Orecon | Series A | 24M |
| 9/2005 | Pelikon | Series E | 9.2M |
| 5/2004 | PowderMed | Series A | 35.8M |
| 7/2010 | Farfetch | Series A | 4.5M |
| 7/2009 | Avila Therapeutics | Series B | 30M |
| 8/2007 | Avila Therapeutics | Series A | - |
| 7/2000 | 404 Found! | Series A | 5.7M |
| 10/2010 | Pathwork Diagnostics | Series C | 30M |
| 8/2013 | Acutus Medical | Series B | 0 |
| 9/2005 | Algeta | Series A | 28.9M |
| 2/2004 | Pertinence Data Intelligence | Venture Round | 4.3M |
| 9/2010 | OpenCloud | Venture Round | 7.7M |
| 6/2003 | Pelikon | Series C | 5.4M |
| 7/2007 | Ubiquisys | Series B | 25M |
| 7/2013 | Versartis | Series C | 0 |
| 11/2009 | Oxagen | Series C | 0 |
| 10/2003 | Biospect | Series B | 27M |
| 3/2001 | K2 Optronics | Series B | 29M |
| 3/2013 | Farfetch | Series C | 20M |
| 1/2013 | Versartis | Series C | 0 |
| 5/2007 | Conatus Pharmaceuticals | Series A | 22M |
| 2/2011 | Vitrue | Series C | 0 |
| 1/2004 | Pelikon | Series D | 2.7M |
| 9/2010 | Ubiquisys | Venture Round | 0 |
| 6/2003 | Network365 | Series C | 11.7M |
| 9/2006 | Ubiquisys | Series A | 12M |
| 5/2006 | Cardiokine | Series B | 50M |
| 2/2009 | BridgeCo | Venture Round | 6M |
| 2/2011 | Versartis | Series B | 21M |
| 10/2006 | Qype | Series A | - |
| 9/2008 | Qype | Series A | 11.3M |
| 11/2002 | Pelikon | Series B | 4M |
| 8/2012 | Ubiquisys | Venture Round | 19M |
| 7/2010 | Ubiquisys | Venture Round | 9M |
| 6/2011 | WorldStores | Debt Financing | 13.9M |
| 8/2007 | Dailymotion | Series B | 34M |
| 12/2002 | Am-Beo | Series B | 12.5M |
| 7/2008 | OpenCloud | Series B | 10M |
| 9/2012 | F2G | Equity | 30M |
| 3/2015 | WorldStores | Series D | 0 |
| 1/2007 | OpenCloud | Series A | 10.3M |
| 6/2013 | WorldStores | Series C | 0 |
| 10/2001 | Celoxica | Series D | 0 |
| 1/2008 | moveme.com | Venture Round | 6.7M |
| 12/2012 | NeRRe Therapeutics | Series A | 18.4M |
| 9/2006 | NeoGuide Systems | Series C | 25M |
| 7/2006 | Pathwork Diagnostics | Venture Round | 11M |
| 10/2009 | Biocartis | Series A | 14.9M |
| 11/1999 | Adeptra | Series A | 12M |
| 4/2000 | Eqos | Venture Round | 8M |
| 7/2002 | Metaphore Pharmaceuticals | Series C | 30M |
| 5/2009 | EUSA Pharma | Venture Round | - |
| 1/2000 | PrismTech | Series A | - |
| 1/2002 | Radiant Networks Plc | Series C | 23M |
| 9/2003 | Phyworks | Series B | 13.3M |
| 5/2005 | Oxagen | Series B | 0 |
| 10/2009 | The Fizzback Group | Series B | 2.6M |
| 4/2010 | Biocartis | Series B | 40M |
| 2/2007 | Echovox | Series B | 7.5M |
| 10/2013 | Versartis | Series D | 0 |
| 3/2021 | Wiz | Series B | 0 |
| 6/2019 | Acutus Medical | Series D | 0 |
| 3/2015 | WorldStores | Series D | 0 |
| 5/2014 | Farfetch | Series D | 0 |
| 10/2013 | Versartis | Series D | 0 |
| 8/2013 | Acutus Medical | Series B | 0 |
| 7/2013 | Versartis | Series C | 0 |
| 6/2013 | WorldStores | Series C | 0 |
| 3/2013 | Farfetch | Series C | 0 |
| 1/2013 | Versartis | Series C | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
